Search results
Tesla Stock Is Soaring, but It Won’t Top This Level
Barrons.com· 3 hours agoCEO Elon Musk’s pay package is still the main reason responsible for Monday’s upward move. Shares likely won’t top $200 until a more-major event,...
Jayson Tatum Shares Joe Mazzulla's Message to Celtics Entering Game 5 of NBA Finals
Sports Illustrated· 3 hours agoThe Celtics enter Game 5 of the NBA Finals with a chance to turn Monday night's matchup at TD Garden...
XRP $0.5 Entry Denied, Here's What's Next, Is Solana Comeback Getting Postponed? Ethereum (ETH) To...
Investing.com· 19 hours agoXRP has failed to enter the $0.5 zone again, suggesting a massive resistance cluster around that...
Kylian Mbappe suffered a nose injury in France's win over Austria at UEFA Euro 2024
USA TODAY Sports via Yahoo Sports· 2 hours agoFrance will take it ♂️ Les Bleus take the lead off an own goal...
XRP stuck below $0.50 while SEC abandons demand for $2 billion penalty
The Forex Market· 13 hours agoThe SEC’s latest reply to the judge suggests a fine of around $100 million, above the $10 million...
Will we really die from minor scratches in the future? Q&A with antibiotic resistance expert
Medical Xpress· 7 hours agoThe Conversation spoke to James P. O'Gara, a professor of microbiology, about the problem of...
Top 3 Price Prediction Bitcoin, Ethereum, Ripple: Bitcoin retesting its major resistance level
The Forex Market· 20 hours agoBitcoin (BTC) and Ripple (XRP) prices are poised for short-to-midterm corrections, while Ethereum...
Diablo 4 Reveals Midseason Update With Patch Notes
Comic Book· 6 hours agoDiablo 4 Season 4's midseason update is now live.
What does the world's rarest album sound like?
BBC via Yahoo News· 6 minutes agoShe gallantly takes off her jacket in single digit weather to show me a tattoo on the back of her neck, a t-shirt from the Opera House show that...
Researchers discover promising approach to prevent recurrence of breast cancer
Medical Xpress· 6 hours agoAlthough treatment outcomes for breast cancer have significantly improved through new research-based therapies, it remains the second most common fatal cancer in women. A particular challenge ...